Epic Medical Research Joins hyperCORE International to Advance Clinical Trials

hyperCORE International, a global partner site network of leading clinical research organizations, has announced the addition of Epic Medical Research to its expanding network. Based in Dallas, Texas, Epic Medical Research operates across 12 state-of-the-art locations, specializing in a wide range of therapeutic areas including metabolic disorders, fatty liver disease, and more. With advanced facilities like Phase I units and an on-site sleep lab, Epic is poised to enhance hyperCORE's capabilities in clinical trials from early development to late-phase execution. Dr. Haresh Boghara of Epic highlighted the partnership as a transformative step towards advancing clinical research and improving patient outcomes, leveraging hyperCORE's resources and shared expertise. Nicholas Focil of hyperCORE praised Epic's therapeutic breadth and operational scale, emphasizing the alignment with hyperCORE's mission for elevated trial performance. Since its founding in 2019, hyperCORE has grown to include over 80 active trial sites across five countries, completing more than 7,000 studies with over 140,000 participants, all while maintaining a commitment to safety, ethics, and innovation in clinical research.